These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 85506)

  • 21. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study.
    Rosenfeld H; Ornoy A; Shechtman S; Diav-Citrin O
    Br J Clin Pharmacol; 2009 Oct; 68(4):609-17. PubMed ID: 19843064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.
    Sarkar S; Bischoff LA
    Semin Reprod Med; 2016 Nov; 34(6):317-322. PubMed ID: 27741549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperthyroidism associated with pregnancy.
    Goluboff LG; Sisson JC; Hamburger JI
    Obstet Gynecol; 1974 Jul; 44(1):107-16. PubMed ID: 4134902
    [No Abstract]   [Full Text] [Related]  

  • 24. Intrauterine hypothyroidism due to antithyroid-drug therapy for thyrotoxicosis during pregnancy.
    Low LC; Ratcliffe WA; Alexander WD
    Lancet; 1978 Aug; 2(8085):370-1. PubMed ID: 79732
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report.
    Kontoleon P; Ilias I; Koutras DA; Kontogiannis D; Papapetrou PD
    Clin Exp Obstet Gynecol; 2002; 29(4):304-5. PubMed ID: 12635752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A; Kung J
    Expert Opin Drug Saf; 2014 Oct; 13(10):1397-406. PubMed ID: 25156887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.
    Li X; Liu GY; Ma JL; Zhou L
    Clinics (Sao Paulo); 2015 Jun; 70(6):453-9. PubMed ID: 26106966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antithyroid drug therapy in pregnancy. An indication for pregnancy interruption based on fetal indications?].
    Wisser J; Knitza R; Hepp H
    Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):367-70. PubMed ID: 2410322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal hypothyroidism complicating medical treatment of thyrotoxicosis in pregnancy.
    Ibbertson HK; Seddon RJ; Croxson MS
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):521-3. PubMed ID: 51697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Teratogenicity of carbimazole].
    Velin P; Dupont D; Golkar A
    Arch Pediatr; 1998 Nov; 5(11):1289. PubMed ID: 9853073
    [No Abstract]   [Full Text] [Related]  

  • 31. Timing of Shift in Antithyroid Drug Therapy and Birth Defects.
    Andersen SL; Andersen S
    Thyroid; 2019 Jan; 29(1):155-156. PubMed ID: 30458113
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants].
    Lian XL; Bai Y; Xu YH; Dai WX; Guo ZS
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):511-5. PubMed ID: 16202286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of fetal goitrous hypothyroidism: value of direct intramuscular L-thyroxine therapy.
    Corral E; Reascos M; Preiss Y; Rompel SM; Sepulveda W
    Prenat Diagn; 2010 Sep; 30(9):899-901. PubMed ID: 20583327
    [No Abstract]   [Full Text] [Related]  

  • 34. Putting propylthiouracil in perspective.
    Cooper DS; Rivkees SA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1881-2. PubMed ID: 19401361
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of embryopathies with use of antithyroidal medications.
    Andersen SL
    Curr Opin Endocrinol Diabetes Obes; 2017 Oct; 24(5):364-371. PubMed ID: 28639966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fetal goitrous hypothyroidism treated by intra-amniotic levothyroxine administration: case report and review of the literature.
    Kobayashi M; Yagasaki H; Saito T; Nemoto A; Naito A; Sugita K
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1001-1005. PubMed ID: 28771438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
    Mandel SJ; Brent GA; Larsen PR
    Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of hypo- and hyperthyroidism in pregnancy].
    Lind P
    Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of hyperthyroidism in pregnancy].
    Niesert S; von zur Mühlen A
    Dtsch Med Wochenschr; 1982 May; 107(18):705-9. PubMed ID: 7075487
    [No Abstract]   [Full Text] [Related]  

  • 40. [Side-effects of synthetic antithyroid drugs].
    Ducornet B; Duprey J
    Ann Med Interne (Paris); 1988; 139(6):410-31. PubMed ID: 2464962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.